Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHA:603882)
China flag China · Delayed Price · Currency is CNY
31.46
+0.51 (1.65%)
Aug 11, 2026, 3:00 PM CST

SHA:603882 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-102.67-173.24-381.24643.382,7552,220
Depreciation & Amortization
404.59404.59554.03571528.4425.98
Other Amortization
98.1298.1298.4107.5790.46107.99
Loss (Gain) From Sale of Assets
-4.4-4.4-6.36-2.2-3.999.74
Asset Writedown & Restructuring Costs
12.6312.63149.969.771.020.37
Loss (Gain) From Sale of Investments
-0.21-0.21140.82-262.9710.87.29
Provision & Write-off of Bad Debts
369.89369.89618.94488.41255.3171.09
Other Operating Activities
-71.839.82-15.0214.13105.32172.8
Change in Accounts Receivable
742.6742.6263.521,247-2,702-2,116
Change in Inventory
12.2112.2149.89157.42-58.82-107.02
Change in Accounts Payable
-193.55-193.55-413.54-1,633891.851,162
Change in Other Net Operating Assets
---33.19-40.89102.14133.14
Operating Cash Flow
1,1911,202906.351,2311,9482,088
Operating Cash Flow Growth
8.35%32.62%-26.36%-36.81%-6.71%37.09%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-425.24-423.46-446.36-714.75-840.54-952.42
Sale of Property, Plant & Equipment
20.6919.6315.218.9420.3773.23
Cash Acquisitions
----6.7-22.09-
Divestitures
---218.03--
Investment in Securities
-19.9921.72-25.88-150.29-8.52-131.98
Other Investing Activities
14.6611.131.510.232.411.55
Investing Cash Flow
-409.87-370.97-455.53-634.53-848.37-1,010

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-221.89368.84206.2680-
Long-Term Debt Repaid
--181.96-219.76-330.43-295.51-187.63
Net Debt Issued (Repaid)
26.3839.93149.08-124.16-215.51-187.63
Issuance of Common Stock
---41.7636.63342.13
Repurchase of Common Stock
---210-89.99--
Common Dividends Paid
-414.94-413.9-419.57-839.33-609.52-169.98
Other Financing Activities
-15.08-20.23-8.31-50.29-80.17-37.54
Financing Cash Flow
-403.63-394.2-488.8-1,062-868.57-53.03

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.92-13.5510.837.3938.95-11.46
Net Cash Flow
376.5423.28-27.15-458.34269.861,014

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
765.7778.55459.99516.071,1071,136
Free Cash Flow Growth
19.03%69.26%-10.87%-53.39%-2.49%16.77%
Free Cash Flow Margin
12.95%12.91%6.40%6.04%7.16%9.51%
Free Cash Flow Per Share
1.631.660.991.112.372.44
Levered Free Cash Flow
815.37852.16530.61292.07284.4502.44
Unlevered Free Cash Flow
824.04861.34542.13304.82299.18519.66

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
72.4479.71182.67392.94587.14294.69
Change in Working Capital
484.82484.82-253.18-338.27-1,794-926.93